PH12014501909A1 - Method for preparing human immunoglobulin - Google Patents
Method for preparing human immunoglobulinInfo
- Publication number
- PH12014501909A1 PH12014501909A1 PH12014501909A PH12014501909A PH12014501909A1 PH 12014501909 A1 PH12014501909 A1 PH 12014501909A1 PH 12014501909 A PH12014501909 A PH 12014501909A PH 12014501909 A PH12014501909 A PH 12014501909A PH 12014501909 A1 PH12014501909 A1 PH 12014501909A1
- Authority
- PH
- Philippines
- Prior art keywords
- human immunoglobulin
- preparation
- preparing human
- anion exchange
- exchange chromatography
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100410986A CN102532307B (zh) | 2012-02-22 | 2012-02-22 | 一种制备人免疫球蛋白的方法 |
PCT/CN2013/071754 WO2013123889A1 (zh) | 2012-02-22 | 2013-02-22 | 一种制备人免疫球蛋白的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
PH12014501909A1 true PH12014501909A1 (en) | 2014-11-24 |
PH12014501909B1 PH12014501909B1 (en) | 2014-11-24 |
Family
ID=46340458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12014501909A PH12014501909B1 (en) | 2012-02-22 | 2014-08-22 | Method for preparing human immunoglobulin |
Country Status (7)
Country | Link |
---|---|
CN (1) | CN102532307B (ru) |
BR (1) | BR112014020734B1 (ru) |
CO (1) | CO7141451A2 (ru) |
IN (1) | IN2014DN07228A (ru) |
PH (1) | PH12014501909B1 (ru) |
RU (1) | RU2614119C9 (ru) |
WO (1) | WO2013123889A1 (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104356231B (zh) * | 2014-11-10 | 2017-08-08 | 北海开元生物科技有限公司 | 一种有效去除人免疫球蛋白多聚体的方法 |
CN105126100B (zh) * | 2015-09-23 | 2021-01-26 | 成都蓉生药业有限责任公司 | 一种富含IgM的人免疫球蛋白制剂及其制备方法 |
AU2016231646B2 (en) * | 2016-09-26 | 2021-04-08 | Instituto Grifols, S.A. | Method for the preparation of immunoglobulins |
CN108101981B (zh) * | 2018-01-15 | 2019-06-04 | 四川远大蜀阳药业有限责任公司 | 一种静注免疫球蛋白的生产工艺 |
CN109575129B (zh) * | 2018-12-29 | 2022-04-26 | 贵州泰邦生物制品有限公司 | 一种静注人免疫球蛋白的制备工艺 |
CN110330565B (zh) * | 2019-07-11 | 2021-07-30 | 国药集团武汉血液制品有限公司 | 从血浆分离组分ⅰ和ⅲ中提取静注人免疫球蛋白的方法 |
CN111234009A (zh) * | 2020-01-20 | 2020-06-05 | 华兰生物工程重庆有限公司 | 一种去除特异性人免疫球蛋白中IgA和IgM的层析工艺 |
BE1029863B1 (nl) * | 2022-05-10 | 2023-05-12 | Prothya Biosolutions Belgium | WERKWIJZEN VOOR HET PRODUCEREN VAN IMMUNOGLOBULINE G (IgG) PREPARATEN EN/OF OPLOSSINGEN |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4374763A (en) * | 1979-09-17 | 1983-02-22 | Morishita Pharmaceutical Co., Ltd. | Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof |
JPS58180433A (ja) * | 1982-04-16 | 1983-10-21 | Fujirebio Inc | 免疫グロブリンから抗補体作用物質の除去法 |
TR200100303T2 (tr) * | 1998-06-09 | 2001-06-21 | Statens Serum Institut | Damardan uygulanacak immünoglobülinler üretmek için yöntem ve başka immünoglobülin ürünleri. |
ES2606078T3 (es) * | 2004-06-07 | 2017-03-17 | Therapure Biopharma Inc. | Aislamiento de proteínas del plasma |
RU2361612C1 (ru) * | 2007-12-21 | 2009-07-20 | Федеральное Государственное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Иммуноглобулиновая основа для иммунобиологических препаратов и способ ее получения, суппозитории и мазь для профилактики и терапии бактериальных и вирусных заболеваний |
KR101464032B1 (ko) * | 2009-05-27 | 2014-11-27 | 백스터 인터내셔널 인코포레이티드 | 피하 사용을 위한 고 농축 면역글로불린 제제의 제조 방법 |
RU2470664C2 (ru) * | 2010-08-23 | 2012-12-27 | Андрей Германович Лютов | Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом |
-
2012
- 2012-02-22 CN CN2012100410986A patent/CN102532307B/zh active Active
-
2013
- 2013-02-22 IN IN7228DEN2014 patent/IN2014DN07228A/en unknown
- 2013-02-22 BR BR112014020734-8A patent/BR112014020734B1/pt active IP Right Grant
- 2013-02-22 WO PCT/CN2013/071754 patent/WO2013123889A1/zh active Application Filing
- 2013-02-22 RU RU2014135665A patent/RU2614119C9/ru active
-
2014
- 2014-08-22 PH PH12014501909A patent/PH12014501909B1/en unknown
- 2014-09-18 CO CO14207099A patent/CO7141451A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN102532307A (zh) | 2012-07-04 |
BR112014020734A2 (pt) | 2017-08-22 |
IN2014DN07228A (ru) | 2015-04-24 |
CO7141451A2 (es) | 2014-12-12 |
RU2614119C2 (ru) | 2017-03-22 |
WO2013123889A1 (zh) | 2013-08-29 |
BR112014020734B1 (pt) | 2021-03-02 |
RU2614119C9 (ru) | 2017-08-15 |
PH12014501909B1 (en) | 2014-11-24 |
RU2014135665A (ru) | 2016-04-10 |
CN102532307B (zh) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014501909A1 (en) | Method for preparing human immunoglobulin | |
JOP20200091A1 (ar) | جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري | |
PH12015500355A1 (en) | Compounds for the treatment of paramoxyvirus viral infections | |
MX2021002168A (es) | Compuestos antivirales. | |
EA202090675A3 (ru) | Стабилизированные растворимые f-полипептиды rsv до слияния | |
EA201690031A1 (ru) | Стабилизированные растворимые f-полипептиды rsv перед слиянием | |
MY169159A (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
PH12015501558B1 (en) | Human antibodies to respiratory syncytial virus f protein and methods of use thereof | |
MY164352A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use | |
MX337060B (es) | Proceso para preparar una composicion de inmunoglobulina. | |
MX2015007841A (es) | Sistemas de filtración y membranas con flujo intensificado y método para su preparación. | |
PH12015502539A1 (en) | Cenicriviroc compositions and methods of making and using the same | |
EA201590890A1 (ru) | Производные 5-фтор-n-(пиридин-2-ил)пиридин-2-амина, содержащие сульфоксиминовую группу | |
SG10201804817TA (en) | Delayed release compositions of linaclotide | |
IN2014DN09173A (ru) | ||
WO2014178078A3 (en) | Novel cloning, expression & purification method for the preparation of ranibizumab | |
MX351610B (es) | Sales acidas de adicion de 5alfa-hidroxi-6beta-[2-(1h-imidazol-4-i l)etilamino]colestan-3beta-ol. | |
WO2013152274A8 (en) | Epitope- scaffold immunogens against respiratory syncytial virus (rsv) | |
WO2012155226A8 (pt) | Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos | |
WO2013173256A3 (en) | New and improved influenza vaccines | |
WO2013055825A3 (en) | Guanidinyl-substituted polyamides useful for treating human papilloma virus | |
EA201591192A1 (ru) | Антибактериальные соединения | |
WO2014124092A3 (en) | Lamivudine crystalline salts | |
IN2014DN10683A (ru) | ||
EP2924121A4 (en) | MOLECULES AS INHIBITORS OF THE HUMAN IMMUNE WEAKT-VIRUS TYPE 1 (HIV-1), METHOD FOR THE MANUFACTURE THEREOF AND APPLICATIONS THEREOF |